FLJ46321 Inhibitors
The chemical class of FLJ46321 Inhibitors comprises compounds that can potentially inhibit the activity of the FLJ46321 protein by targeting the MAPK/ERK signaling pathway, with which FLJ46321 may be associated. This pathway plays a crucial role in various cellular processes, including cell proliferation, differentiation, and survival.
Direct inhibitors such as U0126, LY3214996, PD0325901, trametinib, SCH772984, AZD6244, selumetinib, PD184352, FR180204, GDC-0994, PD98059, and AZD8330 target key components or regulators of the MAPK/ERK pathway. By inhibiting these molecules, these compounds can interfere with downstream signaling cascades involving FLJ46321, potentially inhibiting its cellular functions indirectly. Understanding the interplay between FLJ46321 and the MAPK/ERK pathway is essential for elucidating its physiological roles and may provide insights into strategies for diseases associated with dysregulated FLJ46321 signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a potent and selective inhibitor of MEK1/2, which are upstream kinases in the MAPK/ERK signaling pathway. FLJ46321 may interact with the MAPK/ERK pathway, and inhibition of MEK1/2 by U0126 can disrupt downstream signaling, potentially inhibiting the function of FLJ46321. | ||||||
LY3214996 | 1951483-29-6 | sc-507299 | 5 mg | $265.00 | ||
LY3214996 is a selective inhibitor of ERK1/2, key effectors in the MAPK/ERK signaling pathway. Inhibition of ERK1/2 by LY3214996 can disrupt downstream signaling cascades involving FLJ46321, potentially inhibiting its cellular functions. | ||||||
Trametinib | 871700-17-3 | sc-364639 sc-364639A sc-364639B | 5 mg 10 mg 1 g | $114.00 $166.00 $947.00 | 19 | |
Trametinib is a selective inhibitor of MEK1/2, key components of the MAPK/ERK signaling pathway. Inhibition of MEK1/2 by trametinib can disrupt downstream signaling cascades involving FLJ46321, potentially inhibiting its cellular functions. | ||||||
SCH772984 | 942183-80-4 | sc-473205 | 5 mg | $370.00 | 5 | |
SCH772984 is a selective inhibitor of ERK1/2, downstream effectors in the MAPK/ERK signaling pathway. By inhibiting ERK1/2 activity, SCH772984 can interfere with downstream signaling pathways involving FLJ46321, potentially inhibiting its cellular functions. | ||||||
GDC0994 | 1453848-26-4 | sc-507297 | 10 mg | $130.00 | ||
GDC-0994 is a potent and selective inhibitor of ERK1/2, downstream effectors in the MAPK/ERK signaling pathway. FLJ46321 may interact with the MAPK/ERK pathway, and inhibition of ERK1/2 by GDC-0994 can disrupt downstream signaling, potentially inhibiting the function of FLJ46321. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a potent and selective inhibitor of MEK1, an upstream kinase in the MAPK/ERK signaling pathway. By inhibiting MEK1 activity, PD98059 can interfere with downstream signaling pathways involving FLJ46321, potentially inhibiting its cellular functions. | ||||||
AZD8330 | 869357-68-6 | sc-364425 sc-364425A | 5 mg 10 mg | $255.00 $450.00 | ||
AZD8330 is a selective inhibitor of MEK1/2, key components of the MAPK/ERK signaling pathway. Inhibition of MEK1/2 by AZD8330 can disrupt downstream signaling cascades involving FLJ46321, potentially inhibiting its cellular functions. | ||||||